Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qingdao Vland Biotech CoSHSE:603739 +1.18%81 PEG Ratio is 7.29 as of Jul. 29, 2026, which is 76% below its 10-year median of 30.18. GuruFocus rates SHSE:603739 with a GF Score™ of 81/100 and a GF Value™ of ¥14.54 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 94 Biotechnology companies, Qingdao Vland Biotech Co ranks worse than 86.17% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Qingdao Vland Biotech Co's PEG Ratio or its related term are showing as below:
SHSE:603739'
s PEG Ratio Range Over the Past 10 Years
Min: 7.04 Med: 30.18 Max: 32.11
Current: 7.29
During the past 12 years, Qingdao Vland Biotech Co's highest PEG Ratio was 32.11. The lowest was 7.04. And the median was 30.18.
SHSE:603739's PEG Ratio is ranked worse than 86.17% of 94
companies
in the Biotechnology industry
Industry Median: 1.885
vs SHSE:603739: 7.29
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Qingdao Vland Biotech Co (SHSE:603739) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Qingdao Vland Biotech Co PEG Ratio Related Terms
Qingdao Vland Biotech Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603739 vs VRTX, REGN, RVMD: PEG Ratio Comparison
For the Biotechnology subindustry, Qingdao Vland Biotech Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao Vland Biotech Co PEG Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Qingdao Vland Biotech Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Qingdao Vland Biotech Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Qingdao Vland Biotech Co (SHSE:603739) has a PEG Ratio of 7.29 as of Jul. 29, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Qingdao Vland Biotech Co and its competitors. This is 76% below median its historical median of 30.18. Over the past decade, Qingdao Vland Biotech Co's PEG Ratio has ranged from 7.04 to 32.11. According to the industry distribution chart, Qingdao Vland Biotech Co ranks #81 out of 94 companies in the Biotechnology industry, placing it in the top 86.2%.
Is Qingdao Vland Biotech Co's PEG Ratio too high?
Qingdao Vland Biotech Co's current PEG Ratio of 7.29 is 76% below median its 10-year median of 30.18. Over the past 10 years, this metric has ranged from a low of 7.04 to a high of 32.11. The Biotechnology industry median PEG Ratio is 1.89. Qingdao Vland Biotech Co's value of 7.29 is 286.7% above this industry median. Based on the distribution chart, Qingdao Vland Biotech Co ranks #81 out of 94 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Qingdao Vland Biotech Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Vland Biotech Co's PEG Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Qingdao Vland Biotech Co ranks #81 out of 94 companies for PEG Ratio. This places Qingdao Vland Biotech Co in the lower half of its industry. The industry median PEG Ratio is 1.89. Qingdao Vland Biotech Co's value of 7.29 is 286.7% above this benchmark. Historically, Qingdao Vland Biotech Co's own PEG Ratio has ranged from 7.04 to 32.11 over the past decade. While the company's 10-year median is 30.18 vs. the industry median of 1.89, Qingdao Vland Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Biotechnology company?
The median PEG Ratio among Biotechnology companies is 1.89, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qingdao Vland Biotech Co's current PEG Ratio of 7.29 is 286.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Qingdao Vland Biotech Co and its competitors. For the Biotechnology industry, the median PEG Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao Vland Biotech Co's current PEG Ratio is 7.29, which is 76% below median its own 10-year median of 30.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Vland Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Vland Biotech Co (SHSE:603739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.54, compared to a current price of ¥11.19 — trading 23% below its estimated fair value. The current PEG Ratio is 7.29, which is 76% below median its 10-year median of 30.18 and 286.7% above the Biotechnology industry median of 1.89. Qingdao Vland Biotech Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Qingdao Vland Biotech Co (SHSE:603739), the current PEG Ratio is 7.29 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao Vland Biotech Co (SHSE:603739) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao Vland Biotech Co stock appears to be undervalued.
The current stock price of ¥11.19 is trading 23% below its estimated GF Value™ of ¥14.54.
GuruFocus considers Qingdao Vland Biotech Co to be Modestly Undervalued.
Key valuation signals for SHSE:603739:
PEG Ratio: 7.29 (76% below median its 10-year median of 30.18)
GF Value™: ¥14.54 vs. price of ¥11.19 (23% below fair value)
Industry Position: 286.7% above the Biotechnology median (#81 of 94)
No single metric tells the full story. See the SHSE:603739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
81GF Score
Get the complete analysis for SHSE:603739
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603739 has been successfully added to your 
